Company / SG&A per Share
GERON CORP SG&A per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.23
FY2024
5-year range
$0.07 / $0.23
FY2020-FY2024
Trend
+27.3%
vs FY2023
Sector context
#198 of 210
Health Care
What the data says
Among 210 Health Care companies, GERON CORP is in the top 6% for sg&a per share. SG&A per Share has increased for 3 consecutive years, from $0.07 in FY2021 to $0.23 in FY2024.
Based on SEC 10-K filings.
0.23 in FY2024 with a 5-year CAGR of +16.9%.
Increased from $0.13 to $0.23 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +49.7%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 210This company $0.23 Sector average $29.50
▼
-99.2% below sector average
Key checks
Key Insights
- GERON CORP's sg&a per share has grown for 3 consecutive years.
- In FY2024, sg&a per share increased 27.3% year-over-year.
- Ranks #198 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.23 | +27.3% |
| FY2023 | $0.18 | +31.5% |
| FY2022 | $0.13 | +100.3% |
| FY2021 | $0.07 | -28.1% |
| FY2020 | $0.09 | -9.5% |
| FY2019 | $0.10 | -11.8% |
| FY2018 | $0.12 | +5.0% |
| FY2017 | $0.11 | +5.9% |
| FY2016 | $0.11 | +6.3% |
| FY2015 | $0.10 | -36.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026